SCHEMBL13312574

SCHEMBL13312574

O=C(O)CCc1ccc(OCc2cccc3c2N(S(=O)(=O)c2ccc4c(c2)OCO4)CC3)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.47
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
PTGER2 P43116 2/20 0.43
FFAR1 O14842 8/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
PKLR P30613 1/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
FFAR4 Q5NUL3 1/20 0.40
RORC P51449 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13312549 0.88 TUBB4A (0.48) MEN1KMT2APTGER2FFAR1FFAR4
SCHEMBL13312546 0.88 PTGER2 (0.48) PTGER2FFAR1MAPTSMN1; SMN2LMNA
SCHEMBL13312572 0.88 PKM (0.42) PKMMEN1ALDH1A1KMT2APTGER2
SCHEMBL13312571 0.88 PTGER2 (0.45) ALDH1A1PTGER2FFAR1MAPTLMNA
SCHEMBL13312556 0.88 PTGER2 (0.48) PTGER2FFAR1SMN1; SMN2LMNAHTT
SCHEMBL13312575 0.87 RXRA (0.47) PTGER2FFAR1MAPTLMNANPC1
SCHEMBL13312547 0.87 PTGER2 (0.44) MEN1KMT2APTGER2FFAR1MAPT
SCHEMBL13312548 0.87 FFAR1 (0.47) PTGER2FFAR1FFAR4RXRARXRB
SCHEMBL13312552 0.86 PTGER2 (0.49) MEN1KMT2APTGER2FFAR1FFAR4
SCHEMBL13312551 0.86 PTGER2 (0.47) PTGER2FFAR1MAPTLMNAFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 PKM 2915/4885MEN1 3086/4885ALDH1A1 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.